Bibliography
Found 135 results
Filters: Author is Ellis, Ronald J [Clear All Filters]
Clinical-neuropathological correlation in HIV in the era of highly active antiretroviral therapy. In: The Neurology of AIDS. The Neurology of AIDS. London: Oxford University Press; 2005. pp. 799-809.
. Association between HIV encephalitis, neurodegeneration and neurocognitive dysfunction. In: Journal of Neurovirology. Vol. 6. Journal of Neurovirology. ; 2000. p. 50.
. Proteomic fingerprints in CSF and blood of HIV-infected patients with neurocognitive disorders. In: The 9th International Symposium on NeuroVirology. The 9th International Symposium on NeuroVirology. Miami Beach, FL; 2009.
The relationship between levels of CD4+ counts and HIV-1 RNA in CSF and plasma in 900 samples. In: Eighth Conference on Retroviruses and Opportunistic Infections. Eighth Conference on Retroviruses and Opportunistic Infections. ; 2001.
. Relationship between neuropsyhchological impairment and post-mortem findings of HIV-associated brain disease. In: Journal of the International Neuropsyhcological Society. Vol. 8. Journal of the International Neuropsyhcological Society. ; 2002. p. 314.
. The utility and limitations of the HIV Dementia Scale. In: Journal of the International Neuropsychological Society. Vol. 8. Journal of the International Neuropsychological Society. ; 2001. p. 160.
. Validation of post-mortem CSF viral load by comparison to ante-mortem viral load and clinical measurements. In: Journal of NeuroVirology. Vol. 9. Journal of NeuroVirology. ; 2003. p. 130.
. Value of neurocognitive status in predicting HIV-related brain disease. In: Journal of the International Neuropsychological Society. Vol. 7. Journal of the International Neuropsychological Society. ; 2001. p. 150.
. Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer. Journal of NeuroVirology [Internet]. 2013 ;19(1):89-101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23341224
Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders. Journal of Neuroimmune Pharmacology [Internet]. 2013 ;8(5):1197-1209. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24292993
. Altered P-glycoprotein expression in AIDS patients with HIV encephalitis. Journal of Neuropathology and Experimental Neurology [Internet]. 2004 ;63(10):1038-47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15535131
. . Alzheimer-type cerebral amyloidosis in the context of HIV infection: implications for a proposed new treatment approach. Res Sq. 2023 .
. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era. J Infect Dis. 2016 ;213(7):1065-73.
Antiretroviral therapy reduces neurodegeneration in HIV infection. AIDS. 2015 ;29(3):323-30.
. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol. 2013 ;19(2):150-6.
Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS. 2018 ;32(14):2005-2015.
. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014 ;82(23):2055-62.
A battery approach for measuring neuropsychological change. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists [Internet]. 2006 ;21(1):83-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16169705
. Better executive function is independently associated with full HIV suppression during combination therapy. AIDS. 2019 ;33(15):2309-2316.
. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. Journal of NeuroVirology [Internet]. 2005 ;11(4):356-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16206458
Can research at the end of life be a useful tool to advance HIV cure?. AIDS. 2017 ;31(1):1-4.
. Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV. J Acquir Immune Defic Syndr. 2020 ;83(1):56-64.
. Catechol-O-methyltransferase polymorphism Val158Met is associated with distal neuropathic pain in HIV-associated sensory neuropathy. AIDS. 2019 ;33(10):1575-1582.
. CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults. Journal of Neuroimmunology [Internet]. 2004 ;157(1-2):185-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15579296
.